Answer-first summary for fast verification
Answer: Model evaluation, the phase where the model's performance is thoroughly assessed on unseen patient data to ensure its effectiveness, compliance, and readiness for deployment under the given constraints., Feature engineering, where the model's input features are selected and transformed to improve model performance, considering the sensitivity of healthcare data.
**Correct Answer: D. Model evaluation** Model evaluation is the final and critical step in the machine learning model development process, especially in a sensitive and regulated field like healthcare. It involves assessing the performance of a trained model on a separate test dataset that the model has not seen during training. This step is crucial for: - **Ensuring Compliance and Accuracy**: Verifying that the model meets HIPAA compliance and achieves high accuracy to prevent misclassification risks. - **Scalability Testing**: Assessing whether the model can handle increasing volumes of patient data without degradation in performance. - **Making Deployment Decisions**: Determining if the model is ready for deployment or if further improvements are necessary based on its performance on unseen data. **Incorrect Options**: - **A. Feature engineering**: While important for model performance, it is part of the data preparation phase, not the final step. - **B. Data collection**: This is the initial step in the machine learning pipeline, far from the conclusion. - **C. Hyperparameter tuning**: This is a step involved in model training and optimization, important but not the final step in the development process. - **E. Both A and C**: While both are important steps in the model development process, neither serves as the conclusive step to assess the model's readiness for deployment under the given constraints.
Author: LeetQuiz Editorial Team
Ultimate access to all questions.
No comments yet.
In the development of a machine learning model for a healthcare application predicting patient readmission risks, the team has completed data collection, feature engineering, model training, and hyperparameter tuning. The application must comply with HIPAA regulations, ensure high accuracy to avoid misclassification risks, and be scalable to handle increasing patient data volumes. Which step is critical to conclude the model development process, ensuring the model's readiness for deployment by rigorously assessing its performance against a separate test dataset under these constraints? Choose the best option.
A
Feature engineering, where the model's input features are selected and transformed to improve model performance, considering the sensitivity of healthcare data.
B
Data collection, the initial phase where raw patient data is gathered and anonymized to comply with HIPAA regulations.
C
Hyperparameter tuning, a critical step in optimizing the model's parameters for better accuracy, especially important given the high stakes of healthcare predictions.
D
Model evaluation, the phase where the model's performance is thoroughly assessed on unseen patient data to ensure its effectiveness, compliance, and readiness for deployment under the given constraints.
E
Both A and C are necessary final steps to ensure the model's readiness for deployment in a healthcare setting.